We evaluated the association between white blood cell counts and long-term mortality rates in 2,129 patients (mean age, 65.3 ± 13.5 yr; 69% men) L ong-term risk stratification after acute myocardial infarction (AMI) is of great importance, because the benefits of costly interventions and medical treatments are greatest in patients who are at higher risk.1 Evidence indicates that inflammation plays a crucial role in the atherosclerotic process, from its initiation, progression, plaque destabilization, triggering of an acute coronary event, and infarction size, to recuperation after AMI has occurred.2-4 Moreover, it has been postulated that the greater the inflammatory response during the acute phase of AMI, the greater the proinflammatory activity during chronic (stable) phases of the disease.5 Several inflammatory biomarkers (such as C-reactive protein and lipoprotein-associated phospholipase A 2 ) have been identified as important for risk stratification after AMI. 6,7 The circulating white blood cell (WBC) count and differential counts are simple, inexpensive-to-test, and readily available inflammatory markers 8 that have been associated with event rates in patients with coronary heart disease. 9,10 In addition, investigators have related high WBC count to death after AMI.11,12 Moreover, Taglieri and colleagues 13 have reported that WBC count is an independent predictor of 3-year death in patients with non-ST-segment-elevation acute coronary syndrome (ACS), yet this predictor did not add prognostic information beyond the Global Registry of Acute Coronary Events (Grace) score. However, prognosis was usually evaluated for a relatively short time in most studies. Investigators have often included WBC count without subtypes, included only a few subtypes, or applied incomparable methodologies. The independent prognostic value of WBC count and its subtypes, adjusted to other risk factors, has been debatable, and its evaluation as part of post-AMI prognostication has not been performed often.We investigated the association of total and differential WBC counts in regard to long-term mortality rates (at 1-, 5-, and 10-yr follow-up) and evaluated the latter values as incremental predictors with use of a validated prognostic tool: the Soroka Acute Myocardial Infarction (SAMI) score, which integrates cardiovascular risk factors and affective comorbidities into an index score.